Nothing Special   »   [go: up one dir, main page]

You seem to have javascript disabled. Please note that many of the page functionalities won't work as expected without javascript enabled.
 
 
Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Article Types

Countries / Regions

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Search Results (6,844)

Search Parameters:
Keywords = older patients

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
16 pages, 783 KiB  
Review
Chronic Kidney Disease and Osteoarthritis: Current Understanding and Future Research Directions
by Rong-Sen Yang, Ding-Cheng Chan, Yao-Pang Chung and Shing-Hwa Liu
Int. J. Mol. Sci. 2025, 26(4), 1567; https://doi.org/10.3390/ijms26041567 (registering DOI) - 13 Feb 2025
Abstract
Chronic kidney disease (CKD) is a significant public health concern. Osteoarthritis (OA), a common form of arthritis, has been shown to have a dramatically increased prevalence, particularly among individuals aged 40–50 and older, in the presence of CKD. Furthermore, CKD may exacerbate the [...] Read more.
Chronic kidney disease (CKD) is a significant public health concern. Osteoarthritis (OA), a common form of arthritis, has been shown to have a dramatically increased prevalence, particularly among individuals aged 40–50 and older, in the presence of CKD. Furthermore, CKD may exacerbate the progression and impact of OA. A survey study revealed that 53.9% of CKD patients undergoing long-term hemodialysis were diagnosed with OA. These findings underscore the potential association between CKD and OA. Uremic toxins, such as indoxyl sulfate, p-cresyl sulfate, transforming growth factor-β, and advanced glycation end-products, are regarded as potential risk factors in various CKD-related conditions, affecting bone and joint metabolism. However, whether these factors serve as a bridging mechanism between CKD and OA comorbidities, as well as their detailed roles in this context, remains unclear. Addressing the progression of OA in CKD patients and identifying effective treatment and prevention strategies is an urgent challenge that warrants immediate attention. This review focuses on describing and discussing the molecular pathological mechanisms underlying CKD-associated OA and the possible therapeutic strategies. Full article
(This article belongs to the Special Issue Molecular Insights on Drug Discovery, Design, and Treatment)
Show Figures

Figure 1

Figure 1
<p>The accumulation of uremic toxins (UTs) during chronic kidney disease (CKD) disrupts the intracellular balance of iron and calcium ions in joint cells, such as chondrocytes and synoviocytes, leading to ferroptosis and senescence, ultimately causing osteoarthritis (OA). In addition, the CKD-MBD-related signaling pathways are used for comparison. UTs promote iron uptake, increasing intracellular iron ions, which in turn trigger the Fenton reaction to enhance ROS. This inhibits the antioxidant system and exacerbates lipid peroxidation. Additionally, the increase in intracellular calcium ions induces senescence and activates the Calpain and NF-κB signaling pathways, releasing the senescence-associated secretory phenotype (SASP). Solid lines indicate established pathways. Dashed lines represent signaling pathways that have been speculated but not fully substantiated. Long-chain fatty acid CoA ligase 4, ACSL4; lysophospholipid acyltransferase 3, LPCAT3; lipoxygenase, LOX; polyunsaturated fatty acids, PUFA; cystine, Cys; glutamate, Glu; glutathione, GSH; glutathione peroxidase 4, GPX4; hypoxia-inducible factor 2α, HIF-2α; Piezo-type mechanosensitive ion channel component 1, Piezo1; transient receptor potential melastatin 7, TRPM7; nuclear factor-κB, NF-κB; senescence-associated β-galactosidase, SA-β-Gal; NADPH oxidase 4, Nox4; reactive oxygen species, ROS; interleukin, IL; transforming growth factor-beta, TGF-β; tumor necrosis factor-α, TNF-α; metalloproteinase, MMP; monocyte chemoattractant protein-1, MCP1; chemokine ligand 2, CCL2. Created with <a href="http://BioRender.com" target="_blank">BioRender.com</a>.</p>
Full article ">
18 pages, 273 KiB  
Article
The Prevalence of Corneal Disorders in Pugs Attending Primary Care Veterinary Practices in Australia
by Wai In Lau and Rosanne M. Taylor
Animals 2025, 15(4), 531; https://doi.org/10.3390/ani15040531 (registering DOI) - 13 Feb 2025
Abstract
Pugs are highly predisposed to corneal disorders, such as brachycephalic ocular syndrome (BOS), due to their disproportionate skull, reduced corneal sensitivity and eyelid anomalies such as distichiasis, entropion and lagophthalmos. The risk of corneal disorders which cause significant suffering is substantial, prompting calls [...] Read more.
Pugs are highly predisposed to corneal disorders, such as brachycephalic ocular syndrome (BOS), due to their disproportionate skull, reduced corneal sensitivity and eyelid anomalies such as distichiasis, entropion and lagophthalmos. The risk of corneal disorders which cause significant suffering is substantial, prompting calls for international efforts to reduce their prevalence. While these debilitating conditions are also likely to be common in pugs in Australia, their prevalence and risk factors have not been reported. The anonymised electronic patient records (EPRs) of 1318 pugs attending 139 primary care veterinary clinics participating in VetCompass Australia (VCA) in 2017 were used to investigate the prevalence of ophthalmological pathologies and associated demographic risk factors. Pugs were diagnosed with overweight/obesity (prevalence: 20.2%, 95% confidence interval {CI}: 18.1–22.4) ophthalmological abnormalities (14.5%, 95% CI: 12.6–16.3), particularly corneal disorders (12.4%, 95% CI: 12–15.7), and other conditions. The most prevalent ophthalmological disorders were corneal ulcers (5.5%, 95% CI: 4.4–6.9), corneal pigmentation (3.6%, 95% CI: 2.8–4.8) and keratoconjunctivitis sicca (KCS) (3.3%, 95% CI: 2.5–4.5). The risk of all corneal disorders increased with age (odds ratio 1.11, 95% CI: 1.07–1.15), and corneal pigmentation, KCS and keratitis were more prevalent in older pugs (a median age of 7.6 years or older), while entropion, neovascularisation and ulcerative keratitis affected younger dogs (a median age of 3 years or under). The underlying BOS conformation defects, exophthalmos, lagophthalmos and distichiasis, and early signs of corneal damage should be identified through detailed examinations during primary care veterinary visits, and affected pugs should be removed from the breeding population and treated to reduce the severity and duration of their suffering. Full article
(This article belongs to the Special Issue Welfare Issues of "Fashionable" Dogs and Cats Breeding)
16 pages, 927 KiB  
Article
Effects of Long COVID in Patients with Severe Coronavirus Disease 2019 on Long-Term Functional Impairments: A Post Hoc Analysis Focusing on Patients Admitted to the ICU in the COVID-19 Recovery Study II
by Junji Hatakeyama, Kensuke Nakamura, Shotaro Aso, Akira Kawauchi, Shigeki Fujitani, Taku Oshima, Hideaki Kato, Kohei Ota, Hiroshi Kamijo, Tomohiro Asahi, Yoko Muto, Miyuki Hori, Arisa Iba, Mariko Hosozawa and Hiroyasu Iso
Healthcare 2025, 13(4), 394; https://doi.org/10.3390/healthcare13040394 - 12 Feb 2025
Viewed by 8
Abstract
Background/Objectives: This study investigated the prevalence of functional impairments and the effects of long COVID on long-term functional impairments in patients with severe COVID-19. Methods: We conducted a nationwide multicenter cohort study in collaboration with nine hospitals, collecting data using self-administered [...] Read more.
Background/Objectives: This study investigated the prevalence of functional impairments and the effects of long COVID on long-term functional impairments in patients with severe COVID-19. Methods: We conducted a nationwide multicenter cohort study in collaboration with nine hospitals, collecting data using self-administered questionnaires from participants aged 20 years or older who were diagnosed with COVID-19, admitted to the intensive care unit (ICU) between April 2021 and September 2021, and discharged alive. Questionnaires regarding daily life, sequela, and functional impairments were mailed to patients in August 2022. The effects of long COVID on functional impairments were examined using a multivariate logistic regression analysis. Results: The survey was completed by 220 patients, with a mean of 416 days after discharge. Among respondents, 20.5% had physical impairments (n = 45), 35.0% had mental disorders (n = 77), and 42.7% had either (n = 94). Furthermore, 77.7% had long COVID (171/220), and the most common symptom was dyspnea (40.0%). The multivariate analysis showed that fatigue/malaise, upper respiratory tract symptoms, myalgia, muscle weakness, decreased concentration, sleep disorder, brain fog, and dizziness were risk factors for functional impairments at one year. Conclusions: Many patients with severe COVID-19 admitted to the ICU still suffered from post-intensive care syndrome even after one year, which manifested in combination with direct symptoms of the original disease, such as long COVID. Full article
(This article belongs to the Special Issue Human Health Before, During, and After COVID-19)
Show Figures

Figure 1

Figure 1
<p>Study outline, flow chart depicting the enrollment of subjects in the present study. COVID-19; coronavirus disease 2019.</p>
Full article ">Figure 2
<p>Twenty-six symptom outcomes were selected from the International Severe Acute Respiratory and Emerging Infections Consortium follow-up questionnaires. The prevalence of symptoms of the International Severe Acute Respiratory and Emerging Infections Consortium. The population of each was 220 cases, and the percentages of symptomatic cases are shown in the figure. From left to right, the percentage of patients who were symptomatic at the time of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (orange), the percentage who had the continuation or development of new symptoms 3 months after the initial SARS-CoV-2 infection, with these symptoms lasting for at least 2 months (Long COVID) (light blue), and the percentage who had persistent symptoms until the questionnaire survey (green).</p>
Full article ">Figure 3
<p>Odds ratios for physical impairments and mental disorders. The results of multiple logistic regression analyses of physical impairments and mental disorders are shown in a forest plot. Functional impairments were adjusted for age, sex, obesity, sequential organ failure assessment scores on intensive care unit admission, delirium, mechanical ventilation, and long COVID symptoms. ED; erectile dysfunction.</p>
Full article ">
23 pages, 5390 KiB  
Article
The Clinical Implications of Inappropriate Therapy in Community-Onset Urinary Tract Infections and the Development of a Bayesian Hierarchical Weighted-Incidence Syndromic Combination Antibiogram
by Adolfo Gómez-Quiroz, Brenda Berenice Avila-Cardenas, Judith Carolina De Arcos-Jiménez, Leonardo Perales-Guerrero, Pedro Martínez-Ayala and Jaime Briseno-Ramirez
Antibiotics 2025, 14(2), 187; https://doi.org/10.3390/antibiotics14020187 - 12 Feb 2025
Viewed by 183
Abstract
Background/Objectives: The rise in multidrug-resistant pathogens complicates UTI management, particularly in empirical therapy. This study aimed to develop and describe a Bayesian hierarchical weighted-incidence syndromic combination antibiogram (WISCA) model to optimize antibiotic selection for adult patients with community-onset UTIs. Methods: A retrospective study [...] Read more.
Background/Objectives: The rise in multidrug-resistant pathogens complicates UTI management, particularly in empirical therapy. This study aimed to develop and describe a Bayesian hierarchical weighted-incidence syndromic combination antibiogram (WISCA) model to optimize antibiotic selection for adult patients with community-onset UTIs. Methods: A retrospective study was conducted using a Bayesian hierarchical model. Data from microbiology laboratory records and medical databases were analyzed, focusing on age, prior antibiotic exposure, and clinical characteristics. Clinical outcomes, including extended hospital stays and in-hospital mortality, were evaluated before WISCA model development. Unlike traditional antibiograms, a WISCA integrates patient-specific factors to improve antimicrobial coverage estimations. A total of 11 monotherapies and 18 combination therapies were tested against 15 pathogens, with posterior coverage probabilities and 95% highest density intervals (HDIs) used to assess coverage. Results: Inappropriate final antibiotic treatment was associated with worse outcomes. The Bayesian framework improved estimations, particularly for rare pathogen–antibiotic interactions, increasing model applicability in high-resistance settings. Combination regimens showed superior coverage, especially in MDR cases and older adults. Conclusions: This study employed a comprehensive methodological approach for WISCA development, enhancing empirical antibiotic selection by incorporating local resistance data and patient-specific factors in a middle-income Latin American country with a high antimicrobial resistance profile. These findings provide a foundation for future clinical applications and antimicrobial stewardship strategies in high-resistance environments. Full article
(This article belongs to the Special Issue The Battle Against Urinary Tract Infections: The Role of Antibiotics)
Show Figures

Figure 1

Figure 1
<p>Flowchart of case selection.</p>
Full article ">Figure 2
<p>Logistic regression analysis for clinical outcomes. Model A includes initial empirical inappropriate therapy (blue dots and lines) as a covariate, while Model B includes inappropriate final treatment (red dots and lines) as a covariate. (<b>a</b>) Multivariate models for hospital mortality; (<b>b</b>) multivariate models for extended hospital stay.</p>
Full article ">Figure 3
<p>Weighted-incidence syndromic combination antibiogram for community-onset urinary tract infections. Blue dots represent the median of the posterior distribution of antibiotic regimens (coverage), and the blue lines indicate the 95% highest density interval (HDI). Red dots represent the WISCA without a Bayesian hierarchical model. Regimens are displayed in descending order of coverage.</p>
Full article ">Figure 4
<p>Weighted-incidence syndromic combination antibiogram for community-onset urinary tract infections across different age subgroups. Dots represent the median of the posterior distribution of antibiotic regimens (coverage), and the lines indicate the 95% highest density interval (HDI). Regimens are displayed in descending order of coverage for the subgroup under 30 years of age.</p>
Full article ">Figure 5
<p>Weighted-incidence syndromic combination antibiogram for community-onset urinary tract infections across subgroups, ordered from left to right: recurrent UTI, prior hospitalization, recent antibiotic use within 90 days, and hemodynamic stability. The <span class="html-italic">X</span>-axis represents the treatment regimens, while the <span class="html-italic">Y</span>-axis indicates the percentage of posterior coverage (dots) and the 95% highest density intervals (HDIs) (lines).</p>
Full article ">Figure 6
<p>Weighted-incidence syndromic combination antibiogram (WISCA) for community-onset urinary tract infections across two subgroups with favorable resistance profiles. The <span class="html-italic">X</span>-axis represents the treatment regimens, while the <span class="html-italic">Y</span>-axis indicates the percentage of posterior coverage (dots) and the 95% highest density intervals (HDIs) (lines).</p>
Full article ">
15 pages, 1404 KiB  
Review
Bleeding Risk in Elderly Patients Undergoing Percutaneous Coronary Intervention: A Comprehensive Review
by Alexander Marschall, Fernando Rivero, David del Val, Teresa Bastante, Edurne López Soberón, Inés Gómez Sánchez, Elena Basabe Velasco, Fernando Alfonso, José María de la Torre Hernández and David Martí Sánchez
J. Clin. Med. 2025, 14(4), 1194; https://doi.org/10.3390/jcm14041194 - 12 Feb 2025
Viewed by 115
Abstract
The care of elderly patients with coronary artery disease (CAD) undergoing percutaneous coronary interventions (PCIs) presents unique challenges due to age-related physiological and functional changes. With the global population aging rapidly, this demographic change affects a growing proportion of individuals requiring PCI. However, [...] Read more.
The care of elderly patients with coronary artery disease (CAD) undergoing percutaneous coronary interventions (PCIs) presents unique challenges due to age-related physiological and functional changes. With the global population aging rapidly, this demographic change affects a growing proportion of individuals requiring PCI. However, advanced age is associated with increased susceptibility to ischemic and bleeding complications, driven by physiological changes such as altered coagulation, vascular stiffness, and declining organ function. These factors complicate the management of CAD, making the balance between reducing thrombotic events and minimizing bleeding risks particularly challenging. Antiplatelet therapy is central to post-PCI management, but its benefits and risks differ significantly in elderly patients compared to younger populations. Tools like the PRECISE-DAPT and ARC-HBR provide guidance on dual antiplatelet therapy duration and bleeding risk stratification. However, their applicability and predictive accuracy in elderly patients remain areas of active investigation. This underscores the need for improved risk assessment methods tailored to the unique needs of aging individuals. In this review, we explore the epidemiological, pathophysiological, and clinical aspects of CAD in elderly patients, emphasizing the impact of aging on disease presentation and outcomes. Furthermore, we assess current risk stratification tools and discuss their limitations in predicting adverse events in older populations. By synthesizing these insights, we aim to highlight the complexities of managing elderly CAD patients and identify opportunities for optimizing personalized care to achieve better outcomes in this vulnerable group. Full article
Show Figures

Figure 1

Figure 1
<p>Pathophysiologic changes in the elderly with impacts on hemorrhagic and thrombotic risk.</p>
Full article ">Figure 2
<p>Changes in the equilibrium of hemostasis associated with aging.</p>
Full article ">Figure 3
<p>Clinical approach to CAD in the elderly.</p>
Full article ">Figure 4
<p>Site of post-discharge bleeding.</p>
Full article ">Figure 5
<p>Adjusted HR for prediction of bleeding events.</p>
Full article ">
17 pages, 548 KiB  
Article
KRAS Mutation Status in Relation to Clinicopathological Characteristics of Romanian Colorectal Cancer Patients
by Elena-Roxana Avădănei, Irina-Draga Căruntu, Irina Nucă, Raluca Anca Balan, Ludmila Lozneanu, Simona-Eliza Giusca, Diana Lavinia Pricope, Cristina Gena Dascalu and Cornelia Amalinei
Curr. Issues Mol. Biol. 2025, 47(2), 120; https://doi.org/10.3390/cimb47020120 - 12 Feb 2025
Viewed by 142
Abstract
Our study’s aim was to evaluate the clinicopathological profile of colorectal cancer (CRC) patients from North-East Romania in relation to the Kirsten rat sarcoma viral oncogene homolog (KRAS). We designed a retrospective study on 108 CRC patients using the fully automated [...] Read more.
Our study’s aim was to evaluate the clinicopathological profile of colorectal cancer (CRC) patients from North-East Romania in relation to the Kirsten rat sarcoma viral oncogene homolog (KRAS). We designed a retrospective study on 108 CRC patients using the fully automated real-time PCR-based molecular testing system, IdyllaTMKRAS Mutation Test (Biocartis, Mechelen, Belgium). Of the patients, 64 (59.3%) were men and 62 (57.4%) were older than the group average, with left bowel location in 38 cases (35.2%), adenocarcinoma NOS in 102 cases (94.4%), mixed histological pattern in 65 cases (60.2%), T3 in 60 patients (55.6%), N2 in 46 patients (42.6%), and 7–12 tumour buds registered in 58 tumours (53.7%). A total of 54 tumour samples (50%) showed KRAS mutation. Statistical comparative analyses associated KRAS mutations with the histopathological pattern (p = 0.018), tumour grade (p = 0.030), depth of invasion (pT) (p < 0.001), lymph node involvement (pN) (p < 0.001), venous vascular invasion (p = 0.048), and tumour buds’ number (p = 0.007). Our results demonstrate the relationship between KRAS mutation and clinicopathological features, with possible impact in clinical tumour stratification and therapeutic management. Full article
Show Figures

Figure 1

Figure 1
<p>Statistically significant relationships between <span class="html-italic">KRAS</span>-mutated genotype and clinicopathological characteristics.</p>
Full article ">
10 pages, 874 KiB  
Article
Acquired Deforming Hypertonia in Afro-Caribbeans: A Cross-Sectional Analysis in Long-Term Care Units
by Nicolas Kerjean, Rishika Banydeen, Bertrand Glize, Michel Bonnet, Patrick Rene-Corail, Maturín Tabue Teguo, Moustapha Dramé, Patrick Dehail and Jose-Luis Barnay
J. Clin. Med. 2025, 14(4), 1192; https://doi.org/10.3390/jcm14041192 (registering DOI) - 12 Feb 2025
Viewed by 161
Abstract
Background: Osteoarticular deformities or contractures in institutionalized elderly individuals, described as acquired deforming hypertonia (ADH), have a multifactorial origin. The reported prevalence of ADH in French Caucasian patients in long-term care units (LTCUs) is 25.6%. To date, ADH in the Caribbean population has [...] Read more.
Background: Osteoarticular deformities or contractures in institutionalized elderly individuals, described as acquired deforming hypertonia (ADH), have a multifactorial origin. The reported prevalence of ADH in French Caucasian patients in long-term care units (LTCUs) is 25.6%. To date, ADH in the Caribbean population has never been studied. We aimed to assess the prevalence and characteristics of ADH in such a population. Materials and Methods: This was a cross-sectional observational study of a French Caribbean population in Martinique in which patients aged 75 years or older were institutionalized in LTCUs during the study period. Data extraction from the medical files of eligible LTCU patients was conducted to assess the prevalence, clinical characteristics, and impact of ADH on patients’ daily care. The assessments were performed collaboratively between the patients’ geriatric team and a PM&R physician. Results: In total, 81 patients were included, with an ADH prevalence of 77.8%. Reported ADH was bilateral (86%) or multiple (66% of patients had ≥5 ADH) and was responsible for major alterations in terms of hygiene, dressing, pain, and skin damage. ADH patients had a high level of dependence (GMP = 924), and this level of dependence was significantly associated with the presence of at least one ADH (p < 0.001) regardless of prior disease. Conclusions: The incidence of ADH in our Caribbean population seems twice as high as that in Caucasian patients, underlining the necessity for this nosological framework to be better recognized, particularly in an insular context. Local campaigns for the prevention and recognition of ADH must be considered, and targeted multidisciplinary protocols need to be established for adapted care in all institutions receiving elderly people. Full article
(This article belongs to the Special Issue Clinical Rehabilitation for Multimorbidity and Multiple Disabilities)
Show Figures

Figure 1

Figure 1
<p>Study flow chart.</p>
Full article ">Figure 2
<p>Association between acquired deformation hypertonia (ADH) presence and caregiver-reported difficulties (linear regression).</p>
Full article ">
9 pages, 236 KiB  
Review
Understanding Pelvic Organ Prolapse: A Comprehensive Review of Etiology, Epidemiology, Comorbidities, and Evaluation
by Ali Ersin Zumrutbas
Soc. Int. Urol. J. 2025, 6(1), 6; https://doi.org/10.3390/siuj6010006 - 12 Feb 2025
Viewed by 181
Abstract
Pelvic organ prolapse (POP) is a prevalent condition characterized by the descent of one or more pelvic organs, such as the bladder, uterus, or rectum, into the vaginal canal due to weakened pelvic floor support. This comprehensive review elucidates the multifactorial etiology of [...] Read more.
Pelvic organ prolapse (POP) is a prevalent condition characterized by the descent of one or more pelvic organs, such as the bladder, uterus, or rectum, into the vaginal canal due to weakened pelvic floor support. This comprehensive review elucidates the multifactorial etiology of POP, which includes genetic predisposition, hormonal changes, obstetric factors, lifestyle influences, and age-related pelvic floor decline. Epidemiological data underscore its rising prevalence, particularly among older women, highlighting disparities across populations and risk factors such as parity and socioeconomic status. POP frequently coexists with significant comorbidities like urinary incontinence, sexual dysfunction, and pelvic pain, which exacerbate its impact on quality of life. Accurate evaluation through patient history, physical examinations, and imaging modalities like ultrasound and MRI is critical for diagnosis and management. The review emphasizes advancements in POP evaluation methods, including the POP-Q system, and explores the interplay of anatomical, functional, and psychosocial factors affecting patient outcomes. Key findings reveal that a tailored and holistic approach to treatment, addressing both anatomical correction and associated symptoms, significantly improves patient outcomes. Surgical interventions can alleviate related comorbidities, including urinary and bowel dysfunctions, as well as enhance body image and sexual function. However, the long-term success of such treatments necessitates continued research into preventive strategies and innovative therapeutic approaches. In conclusion, understanding the complexities of POP’s etiology, epidemiology, and management is vital for mitigating its burden and improving the health and well-being of affected individuals. This review highlights the need for integrated care strategies and further studies to advance diagnostic and therapeutic paradigms. Full article
17 pages, 6547 KiB  
Article
Preventative Effect of Angiotensin Receptor Blockers on Moderate-to-Severe Cerebral Vasospasm Among Patients Who Received Interventions for Aneurysmal Subarachnoid Hemorrhage
by Si Un Lee, Hyoung Soo Byoun, Min Jai Cho, Jeong-Wook Lim, Chang Hyeun Kim and Jae-Seung Bang
Biomedicines 2025, 13(2), 442; https://doi.org/10.3390/biomedicines13020442 (registering DOI) - 11 Feb 2025
Viewed by 262
Abstract
Objectives: We conducted a retrospective study to investigate the effectiveness of angiotensin receptor blockers (ARBs) in preventing moderate-to-severe cerebral vasospasm, which may influence patient outcomes in cases of subarachnoid hemorrhage resulting from aneurysmal rupture. Methods: Between 2016 and 2020, we treated [...] Read more.
Objectives: We conducted a retrospective study to investigate the effectiveness of angiotensin receptor blockers (ARBs) in preventing moderate-to-severe cerebral vasospasm, which may influence patient outcomes in cases of subarachnoid hemorrhage resulting from aneurysmal rupture. Methods: Between 2016 and 2020, we treated 210 patients with aneurysmal subarachnoid hemorrhage (aSAH) caused by a ruptured cerebral aneurysm. We obtained the clinical and radiological characteristics of patients through medical records and divided them into two groups: those who were administered ARBs (ARB group) and those who were not (no-ARB group). Results: A total of 181 patients aged 19 years or older with aSAH, without vascular abnormalities (including vascular malformations and moyamoya disease), were enrolled in this study. The age of the enrolled patients was 59.01 ± 12.98 (mean ± standard deviation), and the sex ratio of males to females was 66:115, with a higher proportion of females. The ARB group had 29 and the no-ARB group had 152 participants. The overall incidence of moderate-to-severe vasospasm was 33.7%. The incidence of moderate-to-severe vasospasm in each group was 13.8% (4 patients) and 37.5% (57 patients), respectively. The Fisher grade (III–IV) [odds ratio (OR) of 2.732 (95% confidence interval [CI]: 1.343–5.560; p = 0.006)] independently increases the risk of moderate-to-severe vasospasm, while older age [OR = 0.963; 95% CI: 0.938–0.989; p = 0.006] and ARB administration [OR = 0.246; 95% CI: 0.079–0.771; p = 0.016] independently decrease this risk. Conclusions: Despite the potential adverse impacts associated with hypotension, the administration of ARBs may provide therapeutic benefits in preventing moderate-to-severe vasospasm. A multicenter randomized double-blind controlled trial is needed to further investigate the efficacy and safety of ARBs in preventing moderate-to-severe vasospasm in aSAH patients who have undergone interventions and are experiencing acute hypertension. Full article
Show Figures

Figure 1

Figure 1
<p>Flow chart of study participant selection.</p>
Full article ">Figure 2
<p>Kaplan–Meier curve depicting the vasospasm-free survival rate based on ARB administration.</p>
Full article ">Figure 3
<p>Case illustration of patient who suffered subarachnoid hemorrhage.</p>
Full article ">Figure 3 Cont.
<p>Case illustration of patient who suffered subarachnoid hemorrhage.</p>
Full article ">Figure 3 Cont.
<p>Case illustration of patient who suffered subarachnoid hemorrhage.</p>
Full article ">Figure 3 Cont.
<p>Case illustration of patient who suffered subarachnoid hemorrhage.</p>
Full article ">
10 pages, 591 KiB  
Article
Evaluation of Neurosurgery Consultations in Hospitalized Geriatric Patients During and After the COVID-19 Pandemic
by Hakan Kina and Hakan Yavuzer
Medicina 2025, 61(2), 315; https://doi.org/10.3390/medicina61020315 - 11 Feb 2025
Viewed by 289
Abstract
Background and Objectives: This study aims to evaluate neurosurgery consultations for elderly patients during and following the COVID-19 pandemic. Materials and Methods: This study included patients aged 65 and older who were hospitalized in non-neurosurgery departments at Istinye University Gaziosmanpasa Medical [...] Read more.
Background and Objectives: This study aims to evaluate neurosurgery consultations for elderly patients during and following the COVID-19 pandemic. Materials and Methods: This study included patients aged 65 and older who were hospitalized in non-neurosurgery departments at Istinye University Gaziosmanpasa Medical Park Hospital and were referred for neurosurgery consultations between 1 April 2020 and 31 May 2024. Patients in the intensive care unit and emergency department were excluded. The period from 1 April 2020 to 30 April 2022 was defined as the pandemic period, and from 1 May 2022 to 31 May 2024 as the post-pandemic period. Results: A total of 123 patients were included in this study, with 57 from the pandemic period and 66 from the post-pandemic period. The average age during the pandemic period was 73.45 years (range: 65–93), compared to 71.09 years (range: 65–94) in the post-pandemic period. During the pandemic, 26.3% of patients were recommended for physical therapy and rehabilitation, 24.6% were advised to undergo surgery, 19.3% received neurology consultations, and 17.5% received medical treatment. In the post-pandemic period, 37.9% were recommended for surgery, 16.7% for neurology, 13.6% for physical therapy and rehabilitation, and 7.6% for medical treatment. Overall, 56.4% of patients accepted surgery. Conclusions: Despite the high prevalence of comorbidities in geriatric patients, appropriate neurosurgical referrals significantly improve treatment success, enhance quality of life and mobility, and reduce mortality. We therefore recommend earlier and more attentive referrals to neurosurgery for elderly patients with relevant symptoms to facilitate timely and effective interventions. Full article
(This article belongs to the Section Surgery)
Show Figures

Figure 1

Figure 1
<p>Patient hospitalization departments during consultation.</p>
Full article ">Figure 2
<p>Diagnoses following consultation.</p>
Full article ">
12 pages, 757 KiB  
Article
Evaluation and Analysis of Costs Associated with Prophylaxis of Recurrent Urinary Tract Infections (RUTIs) in Women
by José Emilio Hernández-Sánchez, Julius Jan Szczesnieski, Bárbara-Yolanda Padilla-Fernández, Carmen González-Enguita, Javier Flores-Fraile and María Fernanda Lorenzo-Gómez
Microorganisms 2025, 13(2), 393; https://doi.org/10.3390/microorganisms13020393 - 11 Feb 2025
Viewed by 151
Abstract
To determine the variations in the costs of the prophylaxis of recurrent urinary tract infections (RUTIs) among different prevention protocols, a prospective observational multicenter study on 1614 women receiving RUTI prophylaxis was conducted. The patient groups were as follows: Group A (n = [...] Read more.
To determine the variations in the costs of the prophylaxis of recurrent urinary tract infections (RUTIs) among different prevention protocols, a prospective observational multicenter study on 1614 women receiving RUTI prophylaxis was conducted. The patient groups were as follows: Group A (n = 444): conventional suppressive antibiotic therapy; Group V (n = 732): polyvalent bacterial vaccine; and Group O (n = 438): other adjuvant measures. The variables were age, body mass index, American Society of Anesthesiologists (ASA) physical status classification scale, cost of prophylaxis, duration of the RUTI, number of visits for primary and specialized care, number of UTIs, cost of urinalysis, urine culture, urine cytology, and days of sick leave. The mean age was 57.71 years but was found to be lower in GV. The mean expenditure on UTI prophylaxis and treatment per patient was EUR 4908.07, but this found to be higher in GO. Emergency primary care visits were more frequent in GA. The ordinary scheduled visits to primary care visits were more frequent in GV and GO. The mean successive visits was 2.47 and was shown to be lower in GV. The mean expenditure on successive visits was EUR 341.64 but was found to be lower in GV. The mean number of UTIs was 4.83 at 3 months after finishing prophylaxis and 5.01 at 12 months, and it was observed to be lower in GV. Less frequent VCU usage, older age, more ASA III, more frequent use of urinalyses, urine cultures, ultrasounds, and CT scans were associated with higher costs. In GO, IVU was associated with higher costs. The total expenditure related to RUTIs is associated with older age and the number of RUTIs, a poorer general health status, and the use of urinary tract ultrasounds and CT scans. The use of VCUs instead of ultrasounds and CT scans is cost-effective in the management of RUTIs in older women. Immunoprophylaxis is more cost-effective in reducing the number of visits to the primary care emergency room, the number of successive visits to the Urology Department, the number of intercurrent infections, and the need for urinalyses, urine cultures, CT scans, and ultrasounds in the primary care emergency room. Full article
(This article belongs to the Special Issue Microbiome and Genitourinary Diseases)
Show Figures

Figure 1

Figure 1
<p>Number of UTIs one year after finishing the prophylaxis in GA, GV, and GO. * GA, one outlier case, ** GO: two outliers cases, *** GV: three outliers cases.</p>
Full article ">Figure 2
<p>Multiple regression association between expenditure and variables.</p>
Full article ">
16 pages, 869 KiB  
Article
Echocardiographic Findings in Jordanian Atrial Fibrillation Patients: Analysis from Jo-Fib Study
by Zaid A. Abdulelah, Kais Al Balbissi, Mohammad Al-Dqour, Ayman Hammoudeh and Ahmed A. Abdulelah
Medicina 2025, 61(2), 314; https://doi.org/10.3390/medicina61020314 - 11 Feb 2025
Viewed by 233
Abstract
Background and Objectives: Atrial fibrillation (AF) carries a huge socioeconomic burden as it is the most encountered cardiac arrhythmia with a significant morbidity. Echocardiographic (Echo) imaging is of monumental value in providing insight into assessing the cardiac function and anatomy, etiology, and risk [...] Read more.
Background and Objectives: Atrial fibrillation (AF) carries a huge socioeconomic burden as it is the most encountered cardiac arrhythmia with a significant morbidity. Echocardiographic (Echo) imaging is of monumental value in providing insight into assessing the cardiac function and anatomy, etiology, and risk stratification of AF patients, which will ultimately lead to the best management plan. Materials and Methods: A total of 2160 adult patients diagnosed with AF in 18 hospitals and 30 out-patient cardiology clinics in Jordan and 1 hospital in the Palestinian Territories were enrolled in this study from May 2019 to January 2021. Ultimately, 1776 patients were included in the analysis after going through the exclusion criteria. Results: The majority of our participants were found to have normal EF at the time of enrollment, with only 31.6% exhibiting a decreased EF. Only 40% of overall patients had Echo evidence of left ventricular hypertrophy (LVH). These patients were older (70.27 ± 10.1 vs. 66.0 ± 14.3, p < 0.001), more obese (45.2% vs. 37.3%, p-value < 0.001), and had a more frequent occurrence of HTN (89.0% vs. 65.6%, p < 0.001) and DM (49.2% vs. 40.1%, p < 0.001) when compared to patients without LVH. A proportion of 84.2% of female patients had abnormal left atrial (LA) size (>3.8 cm), in contrast to only 53.4% of males (LA > 4.2 cm). Pulmonary hypertension (PH) was only observed in 27.9% of our patients, and when comparing patients with PH vs. patients without PH, decreased EF (<50%) (36.9% vs. 20.6%, p = 0.001), a higher prevalence of OSA (6.7% vs. 3.8%, p = 0.009), female predominance (60.3% vs. 39.7%, p < 0.001), and older age (70.2 ± 10.7 vs. 66.7 ± 13.6, p < 0.001) were observed in patients with PH. Conclusion: This study provides the first reported insights on the atrial fibrillation-related echocardiographic findings in a Middle Eastern population. Notably, our study demonstrates that the majority of the studied population have no evidence of LVH and have preserved EF on baseline. However, LA enlargement was extremely frequent among females but not in males, warranting further evaluation to determine the factors contributing to such a difference. Full article
Show Figures

Figure 1

Figure 1
<p>(<b>A</b>) The prevalence of different CHA2DS2VASC scores in patients with NVAF. The x-axis presents the score and the y-axis presents the percentage. Non-valvular atrial fibrillation = NVAF. (<b>B</b>) The prevalence of different HASBLED scores in patients with NVAF. The x-axis presents the score and the y-axis presents the percentage. Non-valvular atrial fibrillation = NVAF.</p>
Full article ">Figure 2
<p>(<b>A</b>) The prevalence of different CHA2DS2VASC scores among patients with NVAF and other valvular diseases. The x-axis presents the score and the y-axis presents the percentage. Non-valvular atrial fibrillation = NVAF. (<b>B</b>) The prevalence of different HASBLED scores among patients with NVAF and other valvular diseases. The x-axis presents the score and the y-axis presents the percentage. Non-valvular atrial fibrillation = NVAF.</p>
Full article ">
13 pages, 243 KiB  
Article
Severe Respiratory Infections in Rheumatoid Arthritis Patients: An Observational Study of 528 Patients from a Single University Hospital
by Lucía C. Domínguez-Casas, Iván Ferraz-Amaro, Santos Castañeda and Ricardo Blanco
J. Clin. Med. 2025, 14(4), 1174; https://doi.org/10.3390/jcm14041174 - 11 Feb 2025
Viewed by 226
Abstract
Patients with rheumatoid arthritis (RA) have an increased risk of infections. This may be linked to disease-related factors, immunosuppressive therapy and the presence of comorbidities. Background/Objectives: In an unselected group of RA patients, our aims were to assess the following: (a) the incidence [...] Read more.
Patients with rheumatoid arthritis (RA) have an increased risk of infections. This may be linked to disease-related factors, immunosuppressive therapy and the presence of comorbidities. Background/Objectives: In an unselected group of RA patients, our aims were to assess the following: (a) the incidence and (b) features of diseases and (c) the predictive factors of severe respiratory infection (SRI). Methods: An observational and retrospective study of all patients with RA included in the vaccination program of our hospital between October 2011 and October 2018 was conducted. The follow-up continued until December 2020. Patients with SRI, defined as those that required hospitalization or at least one dose of intravenous antibiotic treatment in the emergency room, were (a) compared with those not requiring hospital admission and (b) studied for predictive factors of SRI (multivariate analysis adjusted for age and sex). The vaccination program in our hospital includes vaccination against influenza, S. pneumoniae and H. influenzae. Information on the patients, infections and hospitalizations was retrospectively retrieved from the hospital and general physician records. Results: We studied 528 RA patients (409 women/119 men) with a mean age of 58.9 ± 13.2 years. A total of 55 patients (10.4%) suffered 89 SRIs. The median [IQR] number of hospitalizations per patient was 1.5 [1–2]. Patients with an SRI were older, had had RA for longer and had more comorbidities (hypertension, hypercholesterolemia, diabetes and interstitial lung disease). These patients had more ACPA positivity, more extra-articular manifestations and high disease activity at the time of their vaccination. Treatment with glucocorticoids, methotrexate and leflunomide was seen in a higher number of patients. Predictive factors for SRI were age; time of evolution of RA; associated comorbidities, especially hypertension and diabetes; extra-articular manifestations, especially interstitial lung disease; and treatment with glucocorticoids, methotrexate and leflunomide. Conclusions: Despite being included in a vaccination program, about 10% of our patients required hospitalization due to an SRI. The main predictive factors were certain comorbidities, interstitial lung disease and treatment with glucocorticoids. Predicting SRI in RA patients remains an unmet need. Full article
(This article belongs to the Section Immunology)
12 pages, 893 KiB  
Article
Contrast-Induced Nephropathy in Endovascular Patients: A Retrospective Cohort Study from a Vascular Surgery Clinic in Eastern Europe
by Nicu Olariu, Felix-Mihai Maralescu, Flaviu Bob, Iulia Dana Grosu, Razvan Dragota-Pascota, Luciana Marc, Lazar Chisavu, Oana Albai, Ioana Adela Ratiu, Sorin Barac, Andreea Luciana Rață, Adelina Mzi and Adelina Mihaescu
J. Clin. Med. 2025, 14(4), 1172; https://doi.org/10.3390/jcm14041172 - 11 Feb 2025
Viewed by 279
Abstract
Introduction: Contrast-induced nephropathy (CIN) has emerged as a prevalent and serious complication associated with the administration of iodinated contrast media during diagnostic and therapeutic procedures. Given the rising global prevalence of chronic kidney disease(CKD,) it is crucial to gain a deeper understanding of [...] Read more.
Introduction: Contrast-induced nephropathy (CIN) has emerged as a prevalent and serious complication associated with the administration of iodinated contrast media during diagnostic and therapeutic procedures. Given the rising global prevalence of chronic kidney disease(CKD,) it is crucial to gain a deeper understanding of the risks linked to contrast media exposure. Therefore, the aim of this study, conducted at the Vascular Surgery Clinic in a tertiary hospital in Eastern Europe (Timisoara, Romania), is to assess the incidence of CIN and identify its associated risk factors among patients undergoing endovascular interventions. Methods: This retrospective cohort study was conducted using data from patients treated at a vascular surgery clinic in Timisoara, Romania, between 1 January 2018 and 31 December 2023. The study population included adult patients who underwent scheduled endovascular procedures and had serum creatinine measurements both before and after the procedure. Results: A total of 331 patients were included in the analysis (71.42% males with a mean age of 66.79 ± 9.86 years). In total, 9.22% of the patients had CKD, while 23.8% developed CIN. The mean age was significantly higher in the CIN group (68.4 years) compared to the non-CIN group (66.32 years) with a p-value of 0.093, indicating that older age is associated with a higher risk of CIN. A multivariate logistic regression analysis was performed to assess the association between various factors and the development of CIN. Higher hemoglobin levels were associated with reduced odds of CIN (OR = 0.792, 95% CI: 0.659–0.952, p = 0.0148), indicating that anemia is a significant risk factor for CIN, while CKD significantly increased the odds of CIN by 85.8% (OR = 1.858, 95% CI: 1.105–3.125, p = 0.0023), establishing CKD as a critical risk factor for CIN. Conclusions: While anemia and CKD were found to be significant predictors of CIN, further research on a wider population is required to validate these findings and explore additional risk factors. Our study shows that, in the context of elective endovascular procedures, addressing anemia correction and stabilizing creatinine levels to baseline represents a crucial strategy for reducing the risk of CIN. Full article
(This article belongs to the Special Issue Clinical Epidemiology in Chronic Kidney Disease)
Show Figures

Figure 1

Figure 1
<p>Histogram of serum creatinine before procedure.</p>
Full article ">Figure 2
<p>Histogram of serum creatinine 48 h after procedure.</p>
Full article ">Figure 3
<p>Roc curve for logistic regression model.</p>
Full article ">Figure 4
<p>Roc curve for the best model (AIC selected).</p>
Full article ">
9 pages, 225 KiB  
Article
Patient-Reported Donor Site Quality of Life Outcomes Following Fibula Free Flap Reconstruction
by Edgar Ochoa, James Cevallos, Ramon Bustos, Nina Patel, Chase M. Heaton, Rahul Seth, P. Daniel Knott and Andrea M. Park
Craniomaxillofac. Trauma Reconstr. 2025, 18(1), 14; https://doi.org/10.3390/cmtr18010014 - 11 Feb 2025
Viewed by 180
Abstract
Study Design: Retrospective cohort study. Objective: To (1) assess post-operative quality of life (QOL) and functional outcomes of fibula free flap (FFF) donor sites, (2) examine the incidence of post-operative claw toe deformities (CTDs) following FFF harvest, and (3) assess the effect of [...] Read more.
Study Design: Retrospective cohort study. Objective: To (1) assess post-operative quality of life (QOL) and functional outcomes of fibula free flap (FFF) donor sites, (2) examine the incidence of post-operative claw toe deformities (CTDs) following FFF harvest, and (3) assess the effect of flexor hallicus longus (FHL) muscle preservation on the incidence of post-operative CTDs. Methods: Patients aged 18 years or older and at least 6 months from FFF reconstructive surgery completed the Manchester–Oxford Foot Questionnaire (MOXFQ)and the Short-form 36 (SF-36) Questionnaire. The incidence of post-operative CTDs reported by respondents was calculated. We assessed the associations between FHL preservation at time of surgery and QOL and functional outcomes, including the development of post-operative CTDs. Results: Sixty patients completed questionnaires at a mean of 38.3 months from surgery. The cohort consisted of 28 patients in whom the FHL muscle and nerve were preserved and 32 patients in whom they were not. Among respondents, 23.3% (14/60) reported post-operative CTDs. FHL status was not associated with post-operative CTDs or with worse scores in the domains of pain (p = 0.612), walking/standing (p = 0.431), or social functioning (p = 0.400). Overall, majority reported high post-operative QOL. Conclusions: While majority of patients who undergo FFF reconstruction can expect good long-term donor site QOL and functional outcomes, there are risks of functional impairment, including post-operative CTDs. Preservation of FHL muscle did not affect post-operative QOL outcomes or the incidence of CTDs. These data can inform patient QOL expectations following FFF harvest. Full article
Back to TopTop